Filter
565
Filtered Results: 565
Text search:
Chagas
Featured
Recommendations
51
New Publications
97
Language
Document type
No document type
153
Studies & Reports
131
Guidelines
95
Strategic & Response Plan
37
Resource Platforms
35
Fact sheets
35
Manuals
30
Videos
15
Training Material
10
Brochures
8
Infographics
6
Situation Updates
5
Dashboards/Maps
3
App
1
Online Courses
1
Countries / Regions
Global
45
Latin America and the Carribbean
40
Brazil
27
Paraguay
22
Colombia
17
Argentina
17
Venezuela
12
Bolivia
8
Malawi
7
India
7
Mozambique
6
Angola
6
Pakistan
4
Kenya
3
Mexico
3
El Salvador
3
Ghana
3
Africa
3
Guinea-Bissau
3
Germany
3
South–East Asia Region
3
Rwanda
2
Syria
2
Iran
2
Nigeria
2
Zimbabwe
2
Jordan
2
Saudi Arabia
2
Western and Central Europe
2
Portugal
2
Lebanon
2
South Africa
2
Uganda
2
Sudan
2
Ethiopia
2
Iraq
2
Liberia
2
Guatemala
2
Benin
1
Sierra Leone
1
Chile
1
Albania
1
Senegal
1
Burkina Faso
1
Afghanistan
1
Peru
1
Morocco
1
Qatar
1
Italy
1
Tanzania
1
Tunisia
1
Djibouti
1
Namibia
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Libya
1
Botswana
1
Zambia
1
Somalia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
150
Clinical Guidelines
53
Public Health
35
Key Resources
20
Pharmacy & Technologies
14
Women & Child Health
11
Capacity Building
2
Toolboxes
NTDs
267
COVID-19
34
HIV
29
Rapid Response
19
Planetary Health
17
Zika
12
Ebola & Marburg
10
NCDs
10
Global Health Education
10
Mental Health
7
Caregiver
7
Refugee
5
Natural Hazards
4
TB
4
Disability
4
AMR
4
Pharmacy
3
Health Financing Toolbox
3
Cholera
2
Conflict
2
Polio
1
ev Panam Salud Publica. 2020;44;e28. https://doi.org/10.26633/RPSP.2020.28
Chagas is a parasitic disease that affects over 6 million people in the
world. As the disease typically remains asymptomatic for years, new cases
often go unnoticed and unreported, and most people with the disease
are unaware of their condition. Less than 10% of people affected are
diagnosed and...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Research and Reports in Tropical Medicine 2021:12 63–76 . This review focusses on the interactions between the etiologic agent of Chagas disease, Trypanosoma cruzi, and its triatomine vector.
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease is currently endemic and also predicted to be at increased transmission risk under future climate change scenarios. Similarly, an expansion of areas in the United States at increased risk for Chagas disease transmission is also expected over the next several decades under climate chan...
Esta guía está enfocada en emitir recomendaciones para el diagnóstico y el tratamiento de la enfermedad de Chagas, como infección por Trypanosoma cruzi, agente protozoario de una parasitosis sistémica. Metodología: La presente guía de práctica clínica fue confeccionada siguiendo los método...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries.
This project aimed to reduce the risk of vector-borne infection with Chagas disease by
controlling triatomine bugs, the vectors transmitting the parasite of Chagas disease, and
establishing an epidemiological surveillance system with community participation.
Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi. It is a significant public health problem, affecting millions of people worldwide. And although it was described 110 years ago, only two old nitroheterocyclic drugs, benznidazole and nifurtimox, are cu...
The Lancet Regional Health - Americas 2024;30: 100681
Published Online 3 February 2024 https://doi.org/10.1016/j.lana.2024.100681
Chagas disease affects 8-10 million people worldwide, mainly in Latin America. The current therapy for Chagas disease is limited to nifurtimox and benznidazole, which are effective in treating only the acute phase of the disease but with severe side effects. Therefore, there is an unmet need for new...
Website last accessed on 31.03.2023
La Tripanosomiasis Americana o Enfermedad de Chagas es una antropozoonosis,
es decir una enfermedad que afecta tanto al hombre como a numerosos animales
mamíferos y que es producida por un protozoario flagelado de la sangre y de los
tejidos el Trypanosoma cruzi.
Chagas disease is found mainly in endemic areas of 21 continental Latin American countries. The most common way people are infected with Chagas is through the blood-sucking triatomine bugs, also known as ‘kissing bugs’ (or vinchuca, barbeiro, pito, chinche, chipo in different Latin American coun...
Vigilancia por laboratorio de la Enfermedad de Chagas en Colombia – 2024
It is 101 years since Carlos Chagas discovered the parasite responsible for the disease that now bears his name. What progress has been made since this discovery? Here Julie Clayton gives the low-down on Chagas disease.
Chagas disease, or American trypanosomiasis, is a condition that causes gradual organ damage. Without treatment, it can be fatal.
This article explains where the T. cruzi parasite is most common and how it can spread. It also outlines the symptoms of Chagas disease and the treatment options avail...
The Lancet Regional Health Americas Volume 37100832 September 2024
